Skip to main content

1 August 2006

SMITHS Medical, part of the global engineering business Smiths Group, announced today it has launched a new range of advanced embryo replacement catheters in response to the changing needs of fertility specialists.

The Sure-Pro and Sure-Pro Ultra catheters, which will be used for in-vitro fertilisation procedures, are the result of research by Smiths Medical into the changing needs of its customers.

The new range was showcased in June at National Infertility Day - a patient awareness event in London. Patients said they liked the idea that they could see their embryos being released thanks to the Sure-Pro Ultra catheter, which is visible under ultrasound.

Smiths Medical is the global market leader in embryo transfer products consistently striving to innovate its range and offer advanced fertility solutions to its customers.

ENDS

General media enquiries

Contact our global media and communications team at:

Tom Steiner

Tom Steiner

Head of External Communications

+44 (0) 20 7004 1600

Email Arrow right icon

Please note – the press team can only answer enquiries from accredited members of the press.

Related articles

Type 8628VL Mechanical Seal

John Crane unveils game-changing mechanical seal, setting new benchmark for ethane pipeline performance

Read our company news as John Crane has launched a new mechanical seal

Find out more Call to action arrow icon
Davinci Gen V Banner Iamge[39]

Smiths Interconnect announces significant contract win

Read our company news as Smiths Interconnect announces a significant contract win

Find out more Call to action arrow icon
Earth View

Smiths Interconnect welcomes new EU-Canada security and defence partnership 

Find out more Call to action arrow icon
Sign up for updates Call to action arrow icon